Published 12 Aug 2021 | Written By Cadence
Lower adalimumab clearance is associated with an improved clinical outcome for patients with Crohn’s disease and may be a superior pharmacokinetic measure than concentration.
Keep reading
See allGenetic variation in IL28B predicts interferon-induced clearance of HCV
- 12 Aug 2021
A recently published article outlining Genetic variation in IL28B predicts interferon-induced clearance of HCV